Follow-up care over 12 months of patients with prostate cancer in Spain: A multicenter prospective cohort study.
dc.contributor.author | Bonfill, Xavier | |
dc.contributor.author | Martinez-Zapata, María José | |
dc.contributor.author | Vernooij, Robin Wm | |
dc.contributor.author | Sánchez, María José | |
dc.contributor.author | Morales-Suárez-Varela, María | |
dc.contributor.author | Emparanza, José Ignacio | |
dc.contributor.author | Ferrer, Montse | |
dc.contributor.author | Pijoan, José Ignacio | |
dc.contributor.author | Palou, Joan | |
dc.contributor.author | Madrid, Eva | |
dc.contributor.author | Abraira, Víctor | |
dc.contributor.author | Zamora, Javier | |
dc.contributor.author | EMPARO-CU study group | |
dc.date.accessioned | 2025-01-07T12:30:21Z | |
dc.date.available | 2025-01-07T12:30:21Z | |
dc.date.issued | 2021 | |
dc.description.abstract | The therapeutic approach is crucial to prostate cancer prognosis. We describe treatments and outcomes for a Spanish cohort of patients with prostate cancer during the first 12 months after diagnosis and identify the factors that influenced the treatment they received.This multicenter prospective cohort study included patients with prostate cancer followed up for 12 months after diagnosis. Treatment was stratified by factors such as hospital, age group ( | |
dc.identifier.doi | 10.1097/MD.0000000000027801 | |
dc.identifier.essn | 1536-5964 | |
dc.identifier.pmc | PMC8615301 | |
dc.identifier.pmid | 34964747 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC8615301/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1097/md.0000000000027801 | |
dc.identifier.uri | https://hdl.handle.net/10668/24665 | |
dc.issue.number | 47 | |
dc.journal.title | Medicine | |
dc.journal.titleabbreviation | Medicine (Baltimore) | |
dc.language.iso | en | |
dc.organization | Escuela Andaluza de Salud Pública | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | e27801 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Multicenter Study | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.mesh | Aftercare | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Antineoplastic Agents, Hormonal | |
dc.subject.mesh | Brachytherapy | |
dc.subject.mesh | Chemotherapy, Adjuvant | |
dc.subject.mesh | Cohort Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasm Grading | |
dc.subject.mesh | Prospective Studies | |
dc.subject.mesh | Prostate-Specific Antigen | |
dc.subject.mesh | Prostatectomy | |
dc.subject.mesh | Prostatic Neoplasms | |
dc.subject.mesh | Spain | |
dc.subject.mesh | Treatment Outcome | |
dc.title | Follow-up care over 12 months of patients with prostate cancer in Spain: A multicenter prospective cohort study. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 100 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC8615301.pdf
- Size:
- 351.08 KB
- Format:
- Adobe Portable Document Format